Pentoxifylline
NDC Package 76237-225-30
Package Information
Pentoxifylline is a medication used to improve the symptoms of a certain blood flow problem in the legs/arms (intermittent claudication due to occlusive artery disease). Marketed by Mckesson Contract Packaging, this product is identified by NDC 76237-225 and is authorized under FDA application ANDA074425.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 76237 - Mckesson Contract Packaging
- 76237-225 - Pentoxifylline
- 76237-225-30 - 6 BLISTER PACK in 1 BOX, UNIT-DOSE / 5 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK
- 76237-225 - Pentoxifylline
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 76237-225-30 identifies a specific commercial package of 6 blister pack in 1 box, unit-dose / 5 tablet, film coated, extended release in 1 blister pack of Pentoxifylline, labeled by Mckesson Contract Packaging. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Mckesson Contract Packaging on July 08, 1997. The current certification is valid through September 30, 2017.
What are the primary indications for this medication?
This medication is used to improve the symptoms of a certain blood flow problem in the legs/arms (intermittent claudication due to occlusive artery disease). Pentoxifylline can decrease the muscle aching/pain/cramps during exercise, including walking, that occur with intermittent claudication. Pentoxifylline belongs to a class of drugs known as hemorrheologic agents. It works by helping blood flow more easily through narrowed arteries. This increases the amount of oxygen that can be delivered by the blood when the muscles need more (such as during exercise) thereby increasing walking distance and duration.
How is this Mckesson Contract Packaging product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 76237022530. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.